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Abstract 
 
Tuberculosis is a bacterial infection that affects one-third of the global population. The 
pathogen responsible for the vast majority of these cases is Mycobacterium tuberculosis and 
the current vaccines are insufficiently effective. The current vaccine against Tuberculosis is 
the live bacille Calmette-Guérin (BCG) vaccine with efficacy varying between 0% and 60% 
depending on the population demographics. DNA, cellular fractions of the pathogen, and 
subunit vaccines failed to provide protection beyond what the BCG vaccine can provide. 
Streptomyces, phylogenetic relatives of the mycobacteria, have been suggested as 
heterologous systems to formulate new vaccines against Tuberculosis. The main research 
objective of this study is to establish a functional relationship between M. tuberculosis and a 
clinical isolate of streptomyces using enzymatic and immunological profiling. This clinical 
isolate was confirmed to be related to Streptomyces albus. Enzymatic profiling of the culture 
filtrate showed that out of a total of 19 enzyme activities investigated, eight were common 
between S. albus and M. tuberculosis. These were: alkaline phosphatase, esterase lipases 
(C8), lipase (C14), leucine arylamidase, valine arylamidase, acid phosphatase, naphthol-AS-
BI-phosphohydrolase, and β-glucosidase. Highest levels of acid phosphatase activity was 
found in the culture filtrate protein (CFP) fraction of S. albus cultured in media containing 
glycine as a nitrogen source but was highest in the cytoplasmic fractions of cells grown with 
nitrate as a nitrogen source. The opposite was true for alkaline phosphatase where the highest 
activity was detected in the media with asparagine as a nitrogen source. Alanine 
dehydrogenase, alcohol dehydrogenase, and catalase/peroxidase showed highest levels in the 
CFP fraction of the media supplemented with nitrate as the nitrogen source whereas it was 
highest in the cytoplasmic fraction of cells harvested from media with glycine as the nitrogen 
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source. Gelatinase zymography showed that the cytoplasmic fraction of cells grown in 
Sauton’s media with ammonium chloride and nitrate as nitrogen sources contained the 
highest activities. The zymograms showed two distinct bands corresponding to 
approximately 120 kDa and 70 kDa and two minor bands at 48 kDa and 20 kDa. In the CFP 
fraction, one minor band was visible only in the medium with nitrate as a nitrogen source, 
corresponding to approximately 50 kDa in size. Additionally, seven monoclonal antibodies 
specific for seven distinct antigens of M. tuberculosis were used to screen for cross reactivity 
with the secretory fractions of S. albus. Of the seven antibodies, only one (F181-ID3-2) gave 
a positive reaction. This is a monoclonal antibody directed at a specific internal amino acid 
sequence in the secreted acid phosphatase of mycobacteria (SapM). This protein has a size of 
about 28kDa and is implicated in the pathogenesis of M. tuberculosis.   
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1. Introduction 
1.1 Tuberculosis: The Disease 
 
 
Infectious diseases remain one of the leading causes of death worldwide (Morens, 
eat al., 2004). Infections can be caused by parasitic, fungal, viral and bacterial pathogens. 
Each year, approximately 17 million deaths are caused by bacterial infections alone 
(Khaliq et al., 2012). It has been estimated that up to one third of the global population are 
infected with Mycobacterium tuberculosis, the causative agent of Tuberculosis (TB) 
(Schluger and Rom, 1989). 
 
 
Tuberculosis is a fatal disease and considered as the seventh leading cause of death 
in the world comparable to AIDS and malaria (WHO, 2004, Causes of death). It is highly 
associated with human immunodeficiency (HIV), which is determined as the global co- 
infection of M. tuberculosis (Toossi et al., 2001). HIV works to reactivate the infection of 
latent M. tuberculosis (MTB), rapidly raises the danger of the infection, and re-activates 
MTB (Corbett et al., 2003). Therefore, the spreading of HIV epidemic and the 
development of multi-drug resistant strains of M. tuberculosis (MDRTB) is increasing 
which makes the improvement of TB control greatly needed (McShane et al., 2005). In 
2012, the incidence of TB was 58 % in Asia and 27% in African regions, while the lowest 
incidence were recorded in Eastern Mediterranean regions (8%), in Europe (4%), and in 
North American (3%) (WHO, 2013). TB is primarily a respiratory disease affecting the 
lung but can spread from this initial site to other parts of the body producing a 
disseminated infection. During active disease, the pathogen spreads to others through 
droplets released during exhalation and/or coughing (WHO, 2013). The most striking 
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symptoms of the disease include coughing, weight loss, and fever (Moreno et al., 1989). In 
late stage acute disease, blood is observed in mucous released through severe coughing 
(Moreno et al., 1989). 
 
 Early diagnosis of infection and direct application of suitable chemotherapy 
provide the best TB  prognoses. The  standard battery  of diagnostic tests includes 
detection of the acid-fast bacilli in sputum, clinical indicators, and X- ray radiographic 
imaging of the lungs (Brust et al., 2011). Due to costs and other  factors, such as the 
availability  of proper clinical equipment, these  tests are often not prescribed initially. 
Instead, the standard is to use the tuberculin skin test with purified protein derivative 
(PPD) antigens. This test involves simply injecting the PPD, which is prepared from 
sterilized spent culture media of the pathogen, subcutaneously in the forearm. Following 
24 hours after injection, the site is monitored for a delayed-type hypersensitivity reaction 
and the diameter of the reaction is used to determine the result (Figure 1) (Chapman et 
al., 2002) (Brust et al., 2011). A diameter of less than 10 mm is considered negative, 
between 10-14 is considered uncertain, and larger than 14 mm is considered positive 
(Farhat et al., 2006). This test remains the most widely  accepted initial diagnostic for the 
detection of active disease or for previous exposure to the pathogen. This test however 
has several draw backs such as the positive reactions often seen with health care 
workers, the fact that previously vaccinated individuals will also test positive and finally 
the length of time it  
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Figure 1. The Tuberculin or PPD test for the initial diagnosis of TB. An injection of the 
PPD preparation is injected under the skin in the forearm. The diameter of the 
hypersensitivity reaction at the site of the injection is used to determine the test result. 
Reproduced with permission from: Giant Mantoux reaction, by Avasthi, R., Chaudhary, 
S. C., and Mohanty, D. (2009) Indian journal of medical microbiology, 27(1), 78-79. 
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takes to arrive at a conclusion. There are presently a number of alternative tests in use 
particularly in Europe and North America. A test that appears to be gaining popularity is 
the ELISA-based interferon test (The enzyme-linked immunosorbent assay). It is a blood 
test that detects latent TB by measuring the release of interferon (IFN)-γ by lymphocytes 
when exposed to antigens of Mycobacterium tuberculosis (Lalvani and Pareek, 2010).   
 
1.2 Mycobacterium  tuberculosis 
1.2.1 The Pathogen 
 
In 1882 Robert Koch published the first of two reports on tuberculosis and he was 
the first one to implicate the pathogen, M. tuberculosis, as the causative agent for the 
disease (Daniel, 2006). Mycobacteria is a genus of the actinobacteria, the largest 
phylum amongst the bacteria, containing Gram-positive bacteria with genomes rich in 
Guanine and Cytosine (GC rich) (Ventura et al., 2007). Physiologically, members of 
this genus are considered aerobes and thus require high level of oxygen to multiply, 
making the lung a good target for infection. M. tuberculosis is an acid-fast bacillus 
(Flynn, 2004) requiring specialized staining methods for microscopic examination and is 
resistant to many antibiotics (Johnson et al., 2006). This resistance is not acquired but is 
due to the nature of the cell wall of the pathogen. To illustrate, the outer surface of the 
pathogen contains mycolic acids with hydrocarbon chains as long as 70 carbons (Liu et 
al,. 1995). Mycolic acids are lipid-rich that make the cell wall thick and complex 
providing an extremely efficient permeability block (Hoffmann et al., 2008). This 
protects the bacillus against the body’s immune response, so staining this bacterium 
is difficult and protects the pathogen from drying outside the host for long period of time 
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(Rao and Meena, 2010). It is this feature that makes the pathogen resistant to many  
antibiotics as this waxy  surface layer limits diffusion of the antibiotics towards their 
targets inside the cell. There are currently four antibiotics that are used in combination 
therapy for TB including: isoniazid, rifampin, pyrazinamide, ethambutol (WHO, 
2005, New Tuberculosis Therapy Offers Potential Shorter Treatment) (Ginsberg and 
Spigelman 2007). Mycobacteria includes other important human and animal pathogens; 
M. bovis (cattle TB), M. leprae (leprosy), M. marinum (fish pathogen), M. avium (bird 
pathogen), and M. africanum (TB-like signs but less virulent). Some non-pathogenic 
mycobacteria include the vaccine strain M. bovis BCG and the commensal M. smegmatis, 
both of which are common surrogates in research for M. tuberculosis (Gengenbacher and 
Kaufmann, 2012). 
 
1.2.2 Pathology and Immunology 
 
     The morphological characterization of Mycobacteria can be divided in to 
two different metabolic/morphological phases according to environmental conditions 
(immune response in this case). When the host immune response becomes weak, 
vegetative growth is initiated by the pathogen, which causes active Tuberculosis (active 
state). At late stage of infection, when the immune response is robust, host immune 
responses suppress the vegetative growth. This causes latent TB (dormant state) by 
inducing the persistence formation of bacillus, which can survive in this stage for years 
(Scherr and Nguyen, 2009). The majority of TB infected people have latent TB 
characterized by dormant bacilli and less than 1% develops the infection and get active TB 
(Hatzios and Bertozzi, 2011). 
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The infection with M. tuberculosis in humans starts by inhaling droplets 
having a small numbers of bacteria (Kaufmann, 2001). Once in the lung, alveolar 
macrophages engulf the bacilli by the process of phagocytosis. This is an important 
component of the innate immune response and is meant to neutralize and disintegrate the 
pathogen. This neutralization process unfortunately is terminated prematurely within the 
macrophage and the pathogen survives the phagocytic process. Subsequent movement of 
the macrophage to other locations within the body while harboring the bacilli leads to 
release of live bacilli to lymph nodes and other parts of the body. Those that remain in 
the lungs and kill host macrophages and other cells trigger an immune response that 
precipitates the formation of a clot to surround and contain the foci of the infection. 
With time, these transform into granulomatous lesions containing live but dormant 
bacilli. The disease may not develop directly because the bacterium is able to persist 
dormant for many years depending on the health status of the individual and other factors. 
To illustrate, the disease is developed directly after initial infection when the immune 
response is compromised such as by the co-infection with HIV, poor nutrition, or any 
other risk factors. The dormant infection can become activated at some point at a later 
time and cause a disease referred to as reactivation Tuberculosis (Gengenbacher and 
Kaufmann, 2012). 
The mechanisms that play roles in the formation and deformation (fragmentation) 
of the granulomas are complex and involve several T cell populations. T cells play an 
important protective role in TB; these include CD4+ and CD8+ T cell with the profile of T 
helper type 1 cytokine (Hingley- Wilson et al., 2003). Additionally, two main mechanisms 
are associated with the acquired resistance of the immune system: macrophage activation 
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by cytokines and cytolytic activity. Secretion of interferon γ (IFNγ) by T cell populations 
is the significant mediator of macrophage activation and acts with the tumor necrosis 
factor α (TNFα) to stimulate the functions of anti-mycobacterial activity (Kaufmann, 
2002). CD4+ T cells participate in protection against TB by producing lymphotoxin α 
(LTα) and CD8+ T cells kill the bacteria within macrophages by producing granulysin 
and perforin (Kaufmann, 2002). As the cells in the immediate area of these immune 
system reactions synthesize fibrous extracellular material to contain the insult 
granulomatous lesions are formed (Kaufmann, 2002). 
 
1. 2. 3 Phylogenetic Classification of Mycobacteria 
 
 
 
A phylogenetic tree is a genetic tool that constructs an evolutionary relationship 
between organisms (Lodders and Kämpfer, 2007). The most widely used method to 
identify and classify organisms is through the 16S ribosomal RNA (rRNA) gene sequence 
(Datta et al., 2012) because it is conserved in all organisms, it has an optimum size (1,500 
bp), and invariable function (Janda and Abbott, 2007). Based on this type of analysis, a 
phylogenetic relationship has been described within mycobacterial species (Kim et al., 
1999), a high relative similarity have been detected from 94.3% – 100% among the genus 
(Blackwood et al., 2000). To illustrate, some mycobacterial species match the same 
sequence, for example MTB complex members, M. gastri and M. kansasii, M. 
farcinogenes and M. senegalense, M. ulcerans and M. marinum, M. szulgai and M. 
malmoense (Devulder et al., 2005). Mycobacterium is also related to other bacteria such 
as the streptomyces (McGuire et al., 2012) (Figure 2). 
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Figure 2. Phylogenetic classification of Mycobacterium tuberculosis based on 16S rRNA 
gene sequences. Adapted from “The origin and evolution of model organisms” by 
Hedges, S. B. (2002).  
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1.3 Mycobacterium bovis Bacille Calmette-Guérin (BCG) 
 
In 1921, Bacille Calmette Guerin (BCG), derived from M. bovis because its 
similarity with M. tuberculosis in more than 90% of DNA homology (Andersen, 2001), it 
was used for protection against tuberculosis (Pym et al., 2003). BCG was derived from 
a cow infected by bovine tuberculosis (Orme, 2001), and developed by culturing the 
original isolation in different passaging and laboratories production condition of 230 
successive passages (Mahairas et al., 1996). The  Pasteur Institute of  Paris distributed 
BCG  vaccine in several  countries  using  unstandardized culture conditions, so more 
than 14 BCG sub strains used as a BCG vaccine around the world (WHO, 2011, 
Recommendations to Assure the Quality, Safety and Efficacy of BCG Vaccines), are 
genetically, phenotypically, and in their vaccine properties different (Liu et al., 2009). 
BCG strains have been divided regarding to the mutations in the bacilli genome into 
early and late strains. In addition, the early strains, including BCG Moreau-RJ, BCG 
Russia, BCG Tokyo 172-1, BCG Birkhaug and BCG Sweden, have the same characteristics of 
the BCG Pasteur (the original strain) with less deletions and mutations in their genomes than 
the late ones. The late strains include BCG Glaxo (Copenhagen 1077), BCG Pasteur 1173P2, 
BCG Prague, and BCG Danish 1331 (WHO, 2011, Recommendations to Assure the Quality, 
Safety and Efficacy of BCG Vaccines). These differences between the BCG strains were 
explained as being due to mutations caused by continued laboratory passaging of the 
parent M. bovis pathogen (Osborn, 1983).  
 
A number of BCG vaccines are currently in use in various countries around the 
world and with various degrees of efficacies. The BCG vaccine may provide a certain 
level of protection when used at an early age, but not in all cases as pointed out earlier. 
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This protection decreases with age and typically disappears in adulthood (Reece and 
Kaufmann, 2008). Complicating this risk is the fact that individuals successfully 
treated for TB often develop re-activation TB, whereby un-killed bacilli that remained 
dormant during the treatment become active and cause disease at some point in the future 
(Verver et al., 2005, 2001). Researchers have investigated several approaches to create  
different and more efficient vaccines. Some of these approaches include the use of 
heterologous systems (transfer of proteins from one species to another). For example, the 
modified vaccinia ankara virus expressing antigen 85A (MVA85A) vaccine was used as a 
first heterologous enhancement for BCG protection in children who received BCG at birth 
(Scriba et al., 2010). It was shown that this vaccine was more efficacious, safer, and has 
great immunogenicity compared to BCG alone (Tameris et al., 2013). Different live 
microorganism (M. microti, M. vaccae, and M. habana) induces immunological memory 
and are used as mycobacterial antigens expressing vectors. Not one of these non- 
pathogenic mycobacterial vectors shows better protection than BCG. Non-
mycobacterial organisms also used to give high rate of protection such as Salmonella, 
but they had many problems (Arzuaga et al., 2011). Streptomyces has been recommended 
as a candidate for vaccine development against TB because it is phylogenetically related 
to mycobacteria and is well established for heterologous production of proteins (S. 
lividans) for several years (Vallin et al., 2009) 
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1.4 Streptomyces 
 
        Streptomyces was discovered by Waksman and Henrici in 1943 (Anderson and 
Wellington, 2001), and it is one of the actinomycetes that are responsible for producing 
around 70% of the 22,000 recognized bacteriological secondary metabolites (Subramani 
and Aalbersberg, 2012). This soil bacterium is industrially used for heterologous protein 
production (Schaerlaekens et al., 2004), and has the greatest number of species when 
compared to other bacteria and archaea. Moreover, it is a Gram-positive bacterium with 
high guanine and cytosine content in its genome and possesses cell wall composed of 
cytoplasmic membrane surrounded by a mesh of peptidoglycan (Scherr and Nguyen, 
2009). Phylogenetically, it is related to the mycobacteriaceae family (Vallin et al., 2009). 
 
  The morphological phase of streptomyces life cycle is distinct and complex. It is 
similar to that of filamentous fungi, both organisms form vegetative mycelium. In 
addition, the developmental stage of the filamentous streptomyces depends on the 
environmental conditions (antibiotic biosynthesis). If it is favorable, multi-genomic 
hyphae will be produced by substrate mycelia. At late stages when conditions are 
unfavorable  these hyphae septate into spores (Flärdh and Buttner, 2009). 
 
  Streptomyces are amongst the highest producers of bioactive secondary 
metabolites such as various antivirals, antifungals, anti-hypertensive, immunosuppressant, 
and antibacterials (Jensen et al., 2007). Indeed, 75% of medical and commercial 
antibiotics are produced by different species of streptomyces (Ceylan et al., 2008). 
Production of a  number  of secondary  metabolites coincides with the morphological 
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differentiation of these bacteria; the production of antibiotics in liquid cultures is 
normally restricted to the stationary stage (Tieleman et al., 1997). Although streptomyces 
are well known for their antibiotics production, few of these filamentous species 
have pathogenic strains to plants and animals (Lodders and Kämpfer, 2007). Streptomyces 
sp. causes mycetoma: skin and tissue infections and other infections that are 
described as invasive infection (Kapadia et al., 2007). These infections involves 
disseminated and bacteremia diseases, infections of respiratory tract and the central 
nervous system (Datta and Arora, 2012). Immunocompromised patients are the most 
vulnerable to these infections for example whether with HIV infection or on 
immunosuppressives (Datta and Arora, 2012). 
Spores of molds found in damp structures have been shown to induce the 
production of cytokines and nitric oxide (NO); both recognized as inflammatory 
mediators causing respiratory tract syndromes (Hirvonen et al., 1997). However, spores 
of streptomyces that are typically found in moldy houses shows highly  increased 
production of these mediators comparing to other microorganisms spores found in the 
moldy buildings (Hirvonen et al., 1997) and the effective mechanisms are poorly 
understood (Jussila et al., 1999). In addition, the production of NO in the airways plays 
an important role to promote inflammation, tissue damage, edema, 
vasodilatation, and cytotoxicity (Hirvonen et al., 2005). Nitric oxide NO is also 
responsible for macrophage activation, which can kill the bacteria and cytokines 
production such as TNFα and IL-6, which cause allergic inflammation (Hirvonen et 
al., 1997). Moreover, streptomyces create valinomycin in the indoor dust. 
Valinomycin is a toxin that inhibits the Function of human NK cell, which is regulated by 
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Interleukin-18 (IL-18) and Interleukin-15 (IL-15) cytokines. NK cells are response for 
cytokines secretion such as IFNγ and TNFα to active the immune response (Paananen 
et al., 2000). For instant, S. somaliensis is a pathogenic strain and the major cause 
of actinomycotic mycetoma (Kirby et al., 2012). Mycetoma infects tissue and bone 
deeply infection (Kirby and Sangal 2012). It infects men more than women particularly 
those 20 to 40 years old (Fahal 2004). It is considered as a fatal disease because it 
destroys and deforms the tissue by forming tissue masses (Kirby and Sangal 2012). The 
most affected parts of the body are feet (Fahal 2004) and it characterized by swelling, 
drainage and nodule development (Lichon and Khachemoune, 2006). Streptomyces albus 
is another species that is widely recognized as an appropriate host for the heterologous 
production of bioactive secondary metabolites (Zaburannyi et al., 2014). It causes a human 
disease called hypersensitivity pneumonitis or HP (Kagen et al., 1981). HP happens 
because of sensitization to antigens that are derived from organic materials such as 
bacteria (Kupeli et al., 2010). Peritonitis is a non- mycetomic (invasive) infection 
caused by streptomyces species such as S. viridis and it demonstrated by fever, 
abdominal swelling, and discomfort in the abdomen (Datta et al., 2012). Potato scab 
is an important disease that caused by plant pathogenic species of streptomyces 
(Loria et al., 2006): S. acidiscabies, S. ipomoeae, S. scabiei, and S. turgidiscabies (Han et 
al., 2005). Superficial and raised lesions on tuber surface characteristic symptoms of 
common scab of potato (Han et al., 2005). In summary, the infections caused by 
Streptomyces sp. are uncommon and there are no breakpoint antibiotics for this 
pathogen. The common drugs used include TS, amikacin, dapsone alone or combined with 
TS, and amoxicillin-clavulanic acid (Martín et al., 2004). 
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1.5 Research Rationale 
 
The current vaccine against TB is the live Bacille Calmette-Guérin (BCG) vaccine. 
It is not effective, particularly in adult populations, and current efforts are directed at 
investigating new approaches for a better vaccine. Several different approaches to create 
such a vaccine were investigated at various laboratories and included DNA vaccines, 
subunits vaccines, and heterologous systems (salmonella) but with little success. 
Considering the phylogenetic relatedness of mycobacteria and streptomyces, the latter 
may provide an alternate strategy to develop a heterologous carrier of M. tuberculosis 
antigens as a new vaccine. As an initial step towards this goal, an enzymatic and 
immunological profiling of streptomyces will be valuable. Since the interaction of a 
pathogen with its host determines the outcome of an immune response it will be useful to 
compare these physiological and immunological interactions between both microbes and 
the host. The more similar their interaction with the host the more similar the 
immunological response will be. For this to be likely however, both microbes must be 
capable of producing similar types of enzymes that would interact with the host in similar 
ways. Furthermore, immunological profiling of proteins secreted by both microbes would 
uncover any similarities in terms of antigen presentation during the interaction with the 
host. In support of this notion, the genome of S. coelicolor was compared recently with 
those of two pathogenic mycobacterial species: M. tuberculosis and M. bovis. It showed 
a high similarity at the individual gene sequences level: 740 (18.56%) in M. tuberculosis 
and 761 (19.42%) in M. bovis genes have over 50% homology with genes from S. 
coelicolor (Arzuaga et al., 2011). In support of these reports, a BLAST search using SapM 
(secreted acid phosphatase of mycobacteria) amino acid sequence against predicted 
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proteins of streptomyces results in the detection of several homologs with over 50% 
sequence homology. One such homolog is presented in Figure 3. These are bioinformatic 
studies and one must show that these similarities exist at a functional level. This study was 
conducted to see if a pathogenic streptomyces (a clinical isolate related to S. albus) indeed 
synthesizes these gene products by testing for the activities of several enzymes secreted to 
the culture media and by testing for cross reactivity of antibodies directed at M. 
tuberculosis antigens with these gene products.  
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Figure 3. Sequence alignment of Rv3310 (SapM) and a streptomyces homolog. 
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1.6 Research objectives: 
 
The main research objective of this study is to establish a functional relationship 
between M. tuberculosis and S. albus using enzymatic and immunological profiling. This 
will confirm that the relatedness of the two bacteria extends beyond phylogenetics and 
bioinformatic analysis and may  include multiple antigens of value in vaccination. The 
specific objectives are: 
 
(1) Evaluate the levels of 19 enzyme activities in cellular fractions of a clinical isolate 
(S. albus) of streptomyces. These will be compared with the enzymatic profile of M. 
tuberculosis established several years ago by another laboratory. This number of enzymes 
was selected because of the availability of a commercial product (API ZYMe, 
Biomerieaux, QC) that can provide qualitative analysis of 19 enzyme activities. It is a 
large enough number to draw conclusions on common activities found in M. tuberculosis 
and S. albus. 
 
(2) Evaluate the cross reactivity of eight monoclonal antibodies specific for antigens of 
M. tuberculosis. 
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2. Materials and methods 
2.1 Materials 
 
  The streptomyces clinical isolate was kindly provided by the Public Health Agency 
of Canada on September 2011 and was marked as S. albus strain NML no.05-0087. 
Monoclonal antibodies (NR-13607, NR-13804, NR-13605, NR-13817, and NR-13793) 
were provided by bei Resources (a program of the National Institute of Allergy and 
Infectious Diseases, VA, USA). The internal peptide (DNDMHDGSI) of SapM was 
synthesized by GenScript (Piscataway, NJ, USA) and was used to generate the 
monoclonal antibodies ANTI-4287-F181-ID3-2, ANTI-4287-F181-4C2-2, and ANTI-
4287-F181-5F12-2. The antibodies were produced by the National Research Council of 
Canada (NRC, Ottawa, Canada). Yeast Malt (YM) extract, Peptone, tryptic soy broth, 
agarose, acrylamide, sodium dodecyl sulfate, trishydroyxmehtylaminoethane (TRIS), 
ethidium bromide, ethylenediaminetetraacetic acid (EDTA), tetramethylenediamine 
(TEMED), ammonium persulfate, bromophenol blue, Coomassie Brilliant Blue R, 
methanol, and acetic acid were purchased from Sigma-Aldrich CO. (St. Louis, MO, USA). 
Ferric Ammonium Citrate, Ammonium chloride, L-Asparagine, potassium phosphate, 
magnesium Sulfate, glycine, citric acid, and potassium nitrate were purchased from 
Thermo Fisher Scientific Co. (Waltham, MA, USA). All other supplies and reagents were 
purchased from Sigma-Aldrich CO. (St. Louis, MO, USA). 
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2.2 Methods  
2.2.1 Culture Media 
Solid media used for routine culturing of the clinical isolate was the Yeast 
Malt (YM) agar prepared according to the supplier’s instructions. For culturing 
and passaging in liquid media, two types of media were used: tryptic soy broth 
(TSB) and Sauton’s media (minimal media typically used to culture mycobacteria). 
Sauton’s media was prepared as described by Chen et al. ( 2003).  
 
2.2.2 Culture Technique 
 
Sauton’s media was the choice of liquid media for this work because it is a defined 
medium with no protein sources, thus facilitating enzyme assays and establishing growth 
medium for future proteomic work. The clinical isolate was initially inoculated into 
TSB medium from the original plate and incubated for a week at RT. A loopful was then 
spread on YM agar plates having 100 µg /ml ampicillin and incubated at 3°C until 
colonies became visible (24 hours). A colony was selected as the stock pure culture and 
used for all subsequent growth experiments. 
 
2.2.3 Strain Identification 
2.2.3.1 Genomic DNA extraction 
 
  Cells cultured in 30 ml medium were pelleted for 5 min at 4000xg and washed 
twice with 10 ml 10% Sucrose. Then it was mixed with 10 ml lysis buffer. Ten milligram 
lysozyme also was added to the mixture and incubated at 37°C for 20 min. That was 
followed by another incubation in a water bath at 55 °C for 1.5 h with addition of 1.0 ml 
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10% SDS and 5 mg proteinase K. A volume o f  3.6 ml of  5 M Sodium chloride and 
15 ml of chloroform were added and the mixture rotated end over end for 20 min at 6 
rpm. Once more, centrifugation was done at 5000xg for 2 minute, and the supernatant 
was divided into three separate phases, the top phase was the only phase used and it was 
transferred to a new 50 ml Falcon tube with 8 ml 100% isopropanol. DNA appeared after 
few minute and transferred to a new microfuge tube containing 1 ml 70% ethanol, 
centrifuged at 13,000 rpm for 10 min, ethanol removed and dried DNA completely. 
Depending on pellet sizes, pre-warmed buffer was added and the DNA resuspended using 
a pipette. DNA was quantified using a Shimadzu spectrophotometer  with a  built-in 
program for calculating the 260 nm /280 nm ratio. 
 
2.2.3.2 PCR amplification 
 
Two sets of PCR primers were designed to amplify fragment of the 16S ribosomal 
RNA gene. The forward primer sequence: GCAATGCTGGCGGCGTGCTTAACACATG 
and the reverse primer sequence TTGCCCAATCGCCAGTCCCACCTTCG (supplied 
through Invitrogen). PCR amplification was performed in a 50 µL  reaction 
containing: 1 µg DNA template, 5 µL   10x Dream TagTM buffer, 5 µL   of 0.2 µM dNTP 
mix, 1.25u Dream TagTM DNA Polymerase, 1.0 µM of both reverse and forward primers, 
and 30.25 µL nuclease free water. PCR was carried out with primary denaturation 
for 3 min at 94 °C and that followed by 31 cycles of: 30 sec at 94 °C, 1:30 min at 65 °C, 1 
min at 72 °C, with a final incubation at 72 °C for 10 min. The PCR product was 
subsequently purified from agarose gels using QIAquick spin columns (QIAGEN GmbH, 
Germany). 
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2.2.4 Protein analysis 
2.2.4.1 Protein extraction 
 
 The culture was divided between culture filtrate protein (CFP) and whole cell lysate 
(WCL) using 50 ml centrifuge tubes at 4500 rpm for 15 min in Beckman GS 
centrifuge. Centrifugal filter devices with UItracel YM -10 membranes were then used to 
concentrate the culture supernatant. The concentrate (3-5 ml) was dialyzed in dialysis 
tubing (Spectrum) against 1.0 L of 2 mM ammonium Bicarbonate at 4°C overnight. 
Whole cell lysate was prepared by resuspending the pellet in 5 ml distilled water and 
subjected to 5 cycles of 10 sec ON/10 sec OFF of sonication using a Heat Systems 
Ultrasonics (W-220F) cell disruptor while on ice. Protein in the extracts was 
quantitated using the Pierce BCA protein assay kit (Thermo Fisher Scientific CO. 
Waltham, MA, USA). 
 
2.2.4.2 Protein Separation by Electrophoresis 
 
     Proteins of the extracts were concentrated by acid precipitation and were 
subsequently separated into individual components using standard SDS-PAGE. Briefly, 1 
volume of 100% (w/v) Trichloroacetic acid (TCA) was add to 4 volumes of protein 
sample followed by 4°C incubation for 10 min. Then the mixture was centrifuged for 10 
min at 14,000 rpm to pellet the proteins. The pellet was washed three times with 200 µL 
cold acetone and the residual acetone removed by  placing the tube in 95°C heat block for 
5-10 minutes.  The protein samples were finally separated by SDS-PAGE using a vertical 
mini-PAGE electrophoresis system for 90 min at 200 V and 20 mAmp.  
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2.2.5 Enzyme Activity Assays 
2.2.5.1 API ZYM activity assay 
 
The API ZYM system (Biomerieux. QC, Canada) is a ready to use multi enzyme 
assay system which requires only the addition of a small volume of the test media into 
micro wells (cupules) containing the appropriate chromogenic substrate (Table 1). It is 
a rapid and semi-quantitative test of 19 enzyme activities. The samples were added to 
each cupule of the strep by different volume according to the protein concentration 
(500 µL of dissolved protein) sample, placed in the dark, and incubated for 45 min at 
room temperature. Then, 20 µL of Fast Garnet GBC buffer was added as a developer, 
incubated for four hours. The outcome reactions were read according to the reading table 
(API ZYM – REF 25 200).  
 
2.2.5.2 Phosphatase Assay 
 
For quantitative analysis, alkaline and acid phosphatase activities were assessed by 
the release of the yellow colored p-nitrophenol (pNP) from p-nitrophenyl phosphate 
(pNPP) through its hydrolysis. The assay was carried out in a total of 200 µL   reaction 
volume: 20 µL protein sample, 20 µL 20 mM pNPP (Fermentas. Ottawa, Canada), and 160 
µL  0.1 M Tris-HCl ,  buffer pH 6.5 (acid phosphatases), pH 9.6 (alkaline phosphatases), 
incubated at 37 °C for 60 minutes followed with the absorption measurement of the 
reactions at 405 nm using a FLUOstar OPTIMA version 1.30.0 (BMGLABTECH). For 
calculation of specific activities a molar absorption coefficient of 13,800 M-1 cm-1 for p-
nitrophenol was used (Rashamuse, et al., 2009). 
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Table 1. A list of substrates utilized in the API ZYM test to detected enzymes activities. 
Adapted from Adelantado et al. (2007). 
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2.2.5.3 Alanine Dehydrogenase Assay 
 
The activity of this enzyme was assayed by measuring the production of NADH 
from NAD+ according to the method described by Ohashima and Soda (1979). The 
reaction mixture contained 100 µL protein sample, 200 µL H2O, 100 µL 1.0 M L-
alanine, 100 µL 500 mM glycine/KCl buffer (pH 10.5), and 500 µL 4.0 mM NAD+. The 
absorbance was followed for 60 sec, at 30 °C and 340 nm using a Shimadzu UV 
spectrophotometer (Hitachi, Tokyo, Japan). 
 
2.2.5.4 Alcohol Dehydrogenase Assay 
 
For quantitative analysis, alcohol dehydrogenase activities determined by 
measuring the reduction of NAD+ to NADH according to the protocol of Blandino et al. 
(1997). This assay is performed by assembling a reaction of 100 µL protein sample, 200 
µL H2O, 100 µL  1.0 M Tris- HCl buffer pH 8.8, 100 µL 100% ethanol, and 500 µL  
prepared fresh 4.0 mM NAD+. The reaction mixture was incubated for 60 sec at 30 °C 
and the absorption change was read at 340 nm using a spectrophotometer. The specific 
activity was collected using the molar extinction coefficient of 6.22 L/mmol-1.0 cm for 
NADH. 
 
2.2.5.5 Peroxidase Assay 
 
For the activity of this enzyme, a fast and a qualitative test comprises mixing the 
protein sample with a solution of 6% hydrogen peroxide. Liberation of air bubbles, 
indicative of degradation of hydrogen peroxide and generation of oxygen gas, constitutes 
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a positive test. 
2.2.5.6 Catalase Assay 
 
 
The conversion of hydrogen peroxide to oxygen and water was done according 
to the method explained by Beers and Sizer (1952) by mixing 1.0 ml 0.059 M hydrogen 
peroxide, 1.9 ml H2O and 0.1 ml protein sample. At 240 nm and 30 °C, the absorbance 
was read for 60 sec by a Shimadzu UV spectrophotometer (Japan). For calculation of 
specific activities a molar absorption coefficient of 43.6 M-1 cm-1 for peroxidase was 
used (Saczko et al., 2002). 
 
2.2.5.7 Gelatin Zymography 
 
  A qualitative assay of gelatinase activity employed gelatin zymography as 
described by Kleiner and Stetlerstevenson (1994). Protein samples (concentrated without 
acid precipitation and without heating or including reducing agents) were separated using 
standard SDS-PAGE except that gelatin at 1% final concentration was included in the 
acrylamide gel. Following electrophoresis, the proteins was soaked in 100 ml of 2.5% 
Triton X-100 in distilled water. In order to refold the separated protein,  the solution was 
replaced with enzyme buffer and incubated overnight at 37 °C. The following day, the 
gel was stained in Coomassie Brilliant Blue R-250 and destined in water: methanol: acetic 
acid (50:40:10) solution to visualize the active bands in the gels. 
 
2.2.6 Western Blots 
 
Following electrophoresis, proteins were transferred onto nitrocellulose 
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membranes using transfer buffer on a BioRad Trans- Blot cell for an hour at 25 V and 200 
mA. When the transfer is completed, the membrane was incubated in a blocking solution 
of 5% skim milk in TBST. The monoclonal anti-M. tuberculosis antibodies (Table 2) 
were used as primary treatment in appropriate dilutions in TBST buffer, and incubated for 
approximately an hour at room temperature. The membrane was then rinsed in TBST 
three times (10 minutes each at room temperature) and incubated with the secondary 
antibody[Anti-Mouse IgG-alkaline phosphatase] (Sigma). Once more, the membrane 
rinsed three times with TBST for 10 min each. Finally the membrane was kept in a 
premixed BCIP/NBT solution (Sigma. Oakville, Canada) for 10- 15 min to develop 
colour intensity and distilled water was used to stop the reaction. 
 
2.2.8 Statistical analysis 
 
    Significance of variance was determined for triplicate measurements using one-way 
ANOVA. 
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Table 2. A list of the primary antibodies used in the western blots. 
 
 
 
Antibody Antigen 
ANTI-4287, F181-ID3-2 Rv3310 SapM  
 
ANTI-4287, F181-4C2-2  Rv3310 SapM 
 
ANTI-4287, F181-5F12-2 Rv3310 (SapM)  
 
NR-13607 Rv2031c HspX  (α-crystallin) 
 
NR-13804  Rv0475  (iron-regulated heparin-binding hemagglutinin (HBHA)) 
 
NR-13605  Rv0934  (periplasmic phosphate-binding lipoprotein) 
 
NR-13817  Rv1860  (MPT32)) 
 
NR-13793  Rv1908c (catalase-peroxidase) 
 
ANTI-ALADH, F181-5D6-2   ALAD 
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3. Results 
3.1 Confirming the identity of the streptomyces clinical isolate being used in 
the experiments 
 
     Optimization of the PCR amplification reaction produced a unique band equivalent to 
about 1500 bp in size (Figure 4). The primers selected for this experiment were based on 
a report in the GenBank that described the production of a 1444 bp rRNA fragment from 
the genomic DNA of streptomyces as a template. The PCR fragment obtained in this 
study is the appropriate size of approximately 1500 bp. Following purification and 
sequencing of this PCR fragment, a sequence belonging to S. albus was obtained. This 
confirmed the identity and purity of the isolate. 
 
3.2 Optimization of growth media and morphological characterization of S. 
albus 
 
     The composition and pH of growth media can affect the physiology and 
morphology of microorganisms. Literature reports on growth conditions for 
streptomyces are scarce and no reports exist on how growth media and pH affect enzyme 
production in these microorganisms. To ensure that the most diverse of enzyme 
production conditions are covered in this study, a number of different media were 
investigated. S. albus colonies in the presence of 100 µg/ml ampicillin grew best on YM 
agar plates during an overnight incubation at 35 °C (Figures 5 and 6). For the TSB liquid 
medium, growth became visible after a week at 35 °C in a shaker (Figures 7 and 8). 
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Figure 4. PCR amplification of the 16S rRNA gene fragment using purified genomic DNA 
of the streptomyces clinical isolates. A unique band close to 1500 bp was obtained and 
matches the expected size of the 1444 bp fragment expected using the primers 
designed in this experiment. 
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Figure 5. Colony morphology of S. albus on YM agar. The clinical isolate was initially 
inoculated into TSB medium from the original plate and incubated for a weak at RT. A 
loopful was then spread on YM agar plates having 100 µg /ml ampicillin and incubated at 
30 °C (bar: 10 mm).  
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Figure 6. Air mycelia  of S. albus as observed  at 400x magnification (bar: 25 µm).   
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Figure 7. Streptomyces albus grown in Tryptic Soy Broth medium. The growth was 
under conditions of non-shaking and at room temperature. (A) Macroscopic image of the 
culture (bar: 10 mm). (B) A microscopic image (200x) for the same culture stained with 
Toluidine Blue (bar: 50 µm). 
A 
B 
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Figure 8. Streptomyces albus grown in Tryptic Soy Broth medium. The growth was 
under conditions of shaking and at 37°C. (A) A macroscopic image of the culture (bar: 10 
mm). (B) A microscope image of the same culture stained with Toluidine Blue pigment; 
magnification 400x (bar: 25 µm). 
A 
B 
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As it is known that glucose is the best energy source for organism, rapid growth was 
notable in Sauton’s medium containing glucose and ammonium chloride (as a nitrogen 
source). The growth was evaluated 2 days post inoculation and was compared 
with that from media in which ammonium chloride was replaced with glycine as a 
nitrogen source. It was notable that the growth in media containing the glycine was much 
slower (Table 3). However, no growth was detected of S.albus in Sauton’s medium 
with glycerol and ammonium chloride while slow growth was notable in the one with L-
Asparagine through two months from time of inoculation with shaking at 37 °C. To 
facilitate analysis of enzyme activities in the culture supernatant of this bacterium and to 
prepare conditions for future proteomic analysis of secreted proteins a defined simple 
medium that is protein-free is needed. Since streptomyces is a phylogenetic close 
relative of mycobacteria, a protein-free simple medium used in mycobacterial research 
is a logical first choice. Sauton’s medium is considered a minimal medium with a defined 
carbon and nitrogen sources and a few other elements (see material and methods section 
2.1 Culture Media). S.albus grew very well in a variety of Sauton’s formulations (Table 
3). Best growth was observed in Sauton’s medium containing glucose as a carbon source 
and either ammonium chloride or sodium nitrate as nitrogen sources. This is in contrast to 
what is observed in mycobacteria however where the preferred carbon source is 
glycerol and the preferred nitrogen source is L-asparagine (Gouzy et al., 2014). 
 
It has been reported that Streptomyces sp. prefer to grow in neutral to alkaline pH 
(Kontro et al., 2005). In Sauton’s media, the initial pH normally adjusted to 7.4 before 
inoculation with the bacterium. Acidification of growth media is normal following 
 35
growth of bacteria as they produce a variety of organic acids as metabolic waste. This has 
been demonstrated in this study particularly in Sauton’s media containing L-asparagine 
and ammonium chloride as nitrogen sources (Table 4). What is interesting however is 
that in M. tuberculosis and M. bovis BCG, acidification is seen only in Sauton’s media 
containing ammonium chloride as a nitrogen source (M. Saleh, unpublished 
observations)? However, in Sauton’s media containing L-asparagine, the pH of the spent 
culture medium actually becomes alkaline (M. Saleh, unpublished observations). 
Although this difference of pH may be explained by the different metabolic networks 
used in both groups of these bacteria, the significance is that acidification of the culture 
media implies that the bacteria will be experiencing a pH stress response and enzyme 
secretion may reflect that response. It is known for example that acid phosphatases are 
typically produced under acidic conditions (Pradel and Boquet, 1988).  
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Table 3. Optimization of growth conditions for S. albus. Different carbon 
sources (glycerol and glucose) and different nitrogen sources (L-asparagine, 
ammonium chloride, sodium nitrate, and glycine) were used to maximize 
growth of the pathogen. (+) Marked for how thick and fast was the growth 
while (-) marked for non-detectable result during that time.    
 
 
              Medium              Growth  
Glycerol - 
2 months 
        L-Asparagine           Slow growth 
     Ammonium chloride                  - 
Glucose – 
2 days  
        L-Asparagine                 +++ 
    Ammonium chloride               ++++ 
        Sodium nitrate               ++++ 
            Glycine                  - 
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Table 4. Effect of growth of S. albus on media pH. The pH was measured for the four 
Sauton’s media (with different nitrogen sources) following completion of the growth 
experiment. All cultures were in the stationary phase at the completion of the experiment. 
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3.3 Determination of streptomyces enzymes activities 
3.3.1 Qualitative assays - API ZYM test 
 
     Activity of enzymes was quantified using API ZYM. During the incubation 
period, the products of the end metabolism produced and detected as color reactions. 
The outcome reactions were read according to the reading table (API ZYM – REF 25 
200), the first cupule is the control, and always gives very pale yellow color, which 
is used as a measure of the cupules color results. An intense coloration of brown, red, 
and dark yellow or orange color was notable when positive reactions detected and 
the number of marks indicates increase of the coloration (Tables 5 and 6). With 
these different activity profiles of the spent culture media and cytoplasmic extracts, 
it was crucial to confirm the level of differences in the protein profiles amongst the 
different protein preparations. A simple SDS-PAGE profiling showed that indeed the 
compositions of these preparations were different (Figure 9, 10). For the Culture 
filtrate protein result, the medium with ammonium chloride has less bands comparing 
to others, but for the cytoplasmic protein, the less bands were as a result of medium 
containing L-Asparagine. All four spent culture media showed unique bands in terms 
of size as well as in terms of abundance. 
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Table 5. API-ZYM activity assay of S.albus culture filtrate protein. The samples   each 
capsule of the strip by different volume according to the protein concentration, placed in 
dark, and incubated at 45°C, followed by another incubation with the developer (Fast 
Garnet GBC: [0.05 g fast Garnet GBC with 50 ml dH2O]) for four hours at 37°C. The 
number of marks indicates the intensity of coloration rate of enzyme reaction in the 
protein sample of the four Sauton’s medium containing glucose and ammonium chloride 
(M), L-asparagine (S), sodium nitrate (N), or glycine (Y) as nitrogen sources. The number 
of marks (+) means increase of the coloration. 
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Table 6. ZYM activity assay of S.albus cytoplasmic protein. The samples were added to 
each capsule of the strip by different volume according to the protein concentration, 
placed in dark, and incubated for 45 °C, followed by another incubation with the 
developer (Fast Garnet GBC: [0.05g fast Garnet GBC with 50 ml dH2O]) for four hours at 
37 °C. The number of marks indicates the intensity of coloration rate of enzyme reaction 
in the protein sample of the four Sauton’s medium containing glucose and ammonium 
chloride (M), L-asparagine (S), sodium nitrate (N), or glycine (Y) as nitrogen sources. The 
number of marks (+) means increase of the coloration. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 41
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. SDS-PAGE pattern of protein extracts of S. albus. Culture filtrate 
protein preparations were precipitated using 10% (w/v) Trichloroacetic acid (TCA), 
washed with cold acetone, and mixed with 2x sample buffer before separation. (M, protein 
markers). 
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Figure 10. SDS-PAGE pattern of protein extracts of S. albus. Cytoplasmic protein 
preparations were precipitated using 10% (w/v) Trichloroacetic acid (TCA), washed with 
cold acetone, and mixed with 2x sample buffer before separation. (M, protein markers). 
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3.3.2 Phosphatase activity 
 
The API ZYM system showed activity for both acid and alkaline phosphatases but 
since it is a qualitative test, a more quantitative test was needed to compare the effects 
of growth media composition and media pH. The activities of these enzymes were 
quantified by measuring the release of the yellow colored product pNP from the 
substrate pNPP. Having an established molar extinction coefficient it allows for the 
determination of specific enzyme activities. The highest specific activity of acid 
phosphatase was observed in the cytoplasmic protein fraction of the bacterium cultured in 
media with sodium nitrate as a nitrogen source (Figure 11). In the culture filtrate 
proteins fraction however the highest activity was observed in cultures utilizing 
glycine as a nitrogen source (Figure 12). The highest activity in the cytoplasmic 
fractions was 4-fold higher than that observed in the culture filtrate proteins fractions. 
Similarly, the highest specific activity of alkaline phosphatase was observed in the 
cytoplasmic protein fraction of the bacterium cultured in media with sodium nitrate as a 
nitrogen source (Figure 13). In contrast however, the culture filtrate proteins fraction with 
highest activity  was observed in cultures utilizing L-asparagine as a nitrogen source 
(Figure 14). Here again the activity of the cytoplasmic fractions showed in general higher 
activity than those observed in the culture filtrate proteins (up to 6 fold higher). 
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Figure 11. Acid phosphatase activity of S.albus cytoplasmic extracts. The bacterium was 
cultured in Sauton’s media containing glucose as a carbon source and as a nitrogen source 
ammonium chloride (AmCl), L-asparagine (Asp), sodium nitrate (Nit), or glycine (Gly). 
Values are expressed as mean ± SEM. (*,*; P < 0.05). The highest specific activity of acid 
phosphatase was observed in the cytoplasmic protein fraction of the bacterium cultured in 
media with sodium nitrate as a nitrogen source. 
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Figure 12. Acid phosphatase activity of S.albus culture filtrate proteins. The bacterium 
was cultured in Sauton’s media containing glucose as a carbon source and as a nitrogen 
source ammonium chloride (AmCl), L-asparagine (Asp), sodium nitrate (Nit), or glycine 
(Gly). Values are expressed as mean ± SEM. (*,*; P < 0.05). The highest activity was 
observed in cultures utilizing glycine as a nitrogen source. 
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Figure 13. Alkaline phosphatase activity of S.albus cytoplasmic proteins.  The 
bacterium was cultured in Sauton’s media containing glucose as a carbon source and as 
a nitrogen source ammonium chloride (AmCl), L-asparagine (Asp), sodium nitrate (Nit), 
or glycine (Gly). Values are expressed as mean ± SEM. (*,*; P < 0.05). The highest 
specific activity was observed in the cytoplasmic protein fraction of the bacterium 
cultured in media with sodium nitrate as a nitrogen source. 
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Figure 14. Alkaline phosphatase activity of S.albus culture filtrate proteins. The 
bacterium was cultured in Sauton’s media containing glucose as a carbon source and as 
a nitrogen source ammonium chloride (AmCl), L-asparagine (Asp), sodium nitrate (Nit), 
or glycine (Gly). Values are expressed as mean ± SEM. (*,*; P < 0.05). The highest 
activity  was observed in cultures utilizing L-asparagine as a nitrogen source. 
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3.3.3 Alanine dehydrogenase activity 
 
As significant alanine dehydrogenase activity has been reported in the culture 
supernatant of M. tuberculosis, the activity of this enzyme was also investigated in the 
cultures of S. albus. Since this enzyme is considered a cytoplasmic enzyme it was not 
surprising to detect significant activity in the cytoplasmic fractions (Figure 15) with 
particularly high activity in the cytoplasmic fraction of the bacterium cultured in Sauton’s 
media with glycine as a nitrogen source. What was surprising however is the equivalent 
activity detected in the culture filtrate proteins fractions from Sauton’s media containing 
sodium nitrate as a nitrogen source (Figure 16)? 
 
3.3.4 Alcohol dehydrogenase activity 
 
The activity of this enzyme was followed by measuring the formation of 
NADH from the dehydrogenation of ethanol. The activity of this enzyme was negligible 
in both cytoplasmic and culture filtrate proteins fractions of the bacterium cultured in 
Sauton’s medium with L- asparagine as a nitrogen source (Figure 17-18). Low activity 
was also observed in the cytoplasmic fractions from media with sodium nitrate as a 
nitrogen source (Figure 17). Curiously, the culture supernatant fraction of this medium 
showed the highest activity of all fractions tested. 
 
3.3.5 Peroxidase activity 
 
Peroxidase is a test not included in the API ZYM strips. Strong catalase activity 
was observe in both the cytoplasmic and culture filtrate proteins fractions of the 
bacterium cultured in Sauton’s media with either sodium nitrate or glycine as a nitrogen 
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source (Table 7). Although activity was observed in all other fractions, the lowest 
activities were observed in the culture filtrate proteins fractions of the bacterium cultured 
in Sauton’s media with L-asparagine and ammonium chloride as nitrogen sources. 
 
3.3.6 Catalase activity 
 
 
The API ZYM strips used earlier in the work do not include a test for catalase 
activity. Aerobic microorganisms typically produce this class of enzymes in addition to 
catalases to assist with detoxification of reactive oxygen. It was surprising to see a 
“disconnect” between these two activities (compare Table 7 to Figure 19-20). Amongst 
the cytoplasmic fractions significant activity was detected only in cultures of Sauton’s 
media utilizing glycine as a nitrogen source (Figure 19). Equally surprising was the 
finding that the activity of this enzyme was negligible in the culture supernatants from 
cultures in Sauton’s media with L- asparagine as a nitrogen source (Figure 20). 
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Figure 15. Alanine dehydrogenase levels in S. albus cytoplasmic. Values are expressed 
as mean ± SEM. (*, * and **, **; P < 0.05). High activity in the cytoplasmic fraction of 
the bacterium cultured in Sauton’s media with glycine. AmCl (ammonium chloride), Asp 
(asparagine), Nit (nitrate), and Gly (glycine). 
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Figure 16. Alanine dehydrogenase levels in S.albus culture filtrate proteins fractions. 
Values are expressed as mean ± SEM. (*, * and **, **; P < 0.05). The equivalent activity 
detected in the culture filtrate proteins fractions from Sauton’s media containing sodium 
nitrate as a nitrogen source. AmCl (ammonium chloride), Asp (asparagine), Nit (nitrate), 
and Gly (glycine). 
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Figure 17. Alcohol dehydrogenase activity in cytoplasmic proteins of S.albus. Values 
are expressed as mean ± SEM. (P < 0.05). The activity of this enzyme was negligible in 
bacterium cultured in Sauton’s medium with L-asparagine. 
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Figure 18. Alcohol dehydrogenase activity in culture filtrate proteins (b) of S.albus. 
Values are expressed as mean ± SEM. (P < 0.05). The activity of this enzyme was 
negligible in bacterium cultured in Sauton’s medium with L-asparagine. AmCl 
(ammonium chloride), Asp (asparagine), Nit (nitrate), and Gly (glycine). 
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Table 7. Peroxidase activity in the culture filtrate proteins and cytoplasmic fractions of S. 
albus in different Sauton’s medium. Strong catalase activity was observe in both the 
cytoplasmic and culture filtrate proteins fractions of the bacterium cultured in Sauton’s 
media with either sodium nitrate or glycine as a nitrogen source. The number of marks (+) 
means increase of the activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Medium Culture filtrate Cytoplasmic 
L-Asparagine + ++ 
Ammonium chloride + ++ 
Sodium nitrate +++ +++ 
Glycine +++ +++ 
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Figure 19. Catalase activity in cytoplasmic protein fractions of S.albus. Values are 
expressed as mean ± SEM. Significant activity was detected only in cultures of 
Sauton’s media utilizing glycine. AmCl (ammonium chloride), Asp (asparagine), Nit 
(nitrate), and Gly (glycine). 
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Figure 20. Catalase activity in cytoplasmic protein (A) and culture filtrate proteins (B) 
fractions of S.albus. Values are expressed as mean ± SEM. the activity of this enzyme 
was negligible in the culture supernatants from cultures in Sauton’s media with L-
asparagine. 
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3.3.7 Matrix Metalloproteinase/Gelatinase activity 
 
      Gelatin zymography is a powerful technique that is used to detect the ability of 
proteolytic enzymes to degrade gelatin, specifically the matrix metalloproteinase MMP-2 
(gelatinase A) and MMP-9 (gelatinase B) type of enzymes (Toth and Fridman, 2001). 
Figure 20 shows the degradation of gelatin by streptomyces enzymes. Equivalent 
and strong activities were detected in the cytoplasmic fractions from media with 
ammonium chloride and sodium nitrate as nitrogen sources. Potentially five distinct bands 
can be resolved within the gel (Figure 21 A and B). Weaker activity with only  two bands 
could be seen in lanes containing the cytoplasmic fraction of the media with glycine as a 
nitrogen source. These results were obtained regardless of whether CaCl2 or ZnCl2 were 
included in the incubation buffer. The bands correspond to the following approximate 
masses: 120 kDa, 50 kDa, 35 kDa, 23 kDa, and 18 kDa. The only activity detected in the 
culture supernatants was from media containing sodium nitrate as a nitrogen source 
(Figure 21 A) where a single band of approximately50 kDa in size was visible. This was 
reproducible in incubation buffer containing CaCl2 but not ZnCl2. Upon concentration of 
the supernatants and/or prolonged incubation times, more clear bands appear, particularly 
in the supernatant from the media with glycine as a nitrogen source. The gels were Zinc 
chloride in the incubation buffer (Figure 22). Two distance bands at approximately 50 
kDa and 18 kDa can be recognized. The smaller of the two can be recognized in the other 
supernatants. 
 
 
 
 
 
 
 
                  
 58
Panel A 
 
 
 
 
 
 
 
 
 
 
 
 
 
Panel B 
    Culture fluid                       Cytoplasmic 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21. Gelatin zymogram of S. albus fractions. The gels were either developed 
with calcium chloride (A) or with Zinc chloride (B) in the incubation buffer. Potentially 
five distinct bands can be resolved within the gel in cytoplasmic fraction in both and weak 
degradation for the secreted protein in both.   
              M 
kDa 
 
120 
85 
  
 
50 
  
35 
  
25 
20 
  
120 
85 
50 
35 
25 
20 
  
A
m
m
o
n
iu
m
 c
h
lo
ri
d
e
 
L
-A
sp
a
ra
g
in
e
 
S
o
d
iu
m
 N
it
ra
te
 
G
ly
ci
n
e
 
A
m
m
o
n
iu
m
 c
h
lo
ri
d
e
 
L
-A
sp
a
ra
g
in
e
 
S
o
d
iu
m
 N
it
ra
te
 
G
ly
ci
n
e
 
 59
 60
3.4 Cross reactivity with Mycobacteria-specific antibodies 
 
Because of the close phylogenetic relatedness of both mycobacteria and 
streptomyces and the fact both M. tuberculosis and this clinical isolate of S. albus are 
respiratory pathogens, it was anticipated that not only they may share secreted enzymatic 
profile but also protein homologies. At least one secreted enzyme of M. tuberculosis, 
SapM, shares significant sequence homology 55% identity and 71% positively relative .It 
was then decided to extend the enzymatic profiling and perform immunological profiling 
to assess the level of homologies in the secreted proteins of both pathogens. Nine 
different monoclonal antibodies were used for this screening. Two monoclonal antibodies 
generated in our laboratory against peptides from SapM and one against M. tuberculosis 
alanine dehydrogenase (AlaDH) whole protein (Table 8). Six additional monoclonal 
antibodies kindly provided to us by Colorado State University against other secreted 
antigens of M. tuberculosis as indicated in Table 8 below. Of the two anti-SapM 
antibodies used, F181-ID3-2 reacted with two bands of approximately 28 kDa and 21 
kDa size in all four supernatants tested (Figure 23). None of the cytoplasmic extracts 
reacted with this antibody. When culture filtrate proteins of M. bovis BCG are used as a 
positive control, two bands become visible in the western blots developed with anti-
AlaDH antibodies (Figure24).Also, using CFP ofH37Rv as a control, two visible bands in 
the western blot developed with (HspX, NR-13607) - Rv2031c HspX (α-crystallin). 
However, none of the S. albus extracts reacted with this antibody. All other monoclonal 
antibodies fail to react with any proteins in the cytoplasmic or culture supernatant 
fractions tested. The results are summarized in Table 8 below. 
 
 61
 
 
Table 8. Cross reactivity of different Mycobacteria-specific antibodies with protein 
extracts of this clinical isolate of S. albus. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Antibody Type Antigen  Result  
ANTI-4287, F181-5F12-2  Rv3310 (SapM)  - 
NR-13607 Rv2031c  HspX  (α-crystallin) - 
NR-13804  Rv0475  (iron-regulated heparin-binding 
hemagglutinin (HBHA)) 
- 
ANTI-4287, F181-4C2-2  Rv3310 SapM - 
NR-13605   Rv0934  (periplasmic phosphate-binding 
lipoprotein) 
- 
NR-13817   Rv1860  (MPT32)) - 
NR-13793    Rv1908c (catalase-peroxidase) - 
ANTI-ALADH, F181-5D6-2      ALAD + 
ANTI-4287, F181-ID3-2      Rv3310 SapM  + 
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Figure 23. Cross reactivity of Mycobacteria-specific antibody (F181-ID3-2) with 
proteins from S. albus. Arrows indicate locations where positive reactivity was observed. 
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Figure 24. Cross reactivity of Mycobacteria-specific antibody (ANTI-AlaDH) with 
proteins from S. albus. BCG is used as a positive control. (M: protein markers). 
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4. Discussion 
 
 
This study established a functional relationship between S. albus, which is 
known as an appropriate host for the heterologous production of bioactive secondary 
metabolites (Zaburannyi et al., 2014), and M. tuberculosis by comparing their 
enzymatic and immunological profiles. Beginning with the interesting findings in the 
growth experiments of S. albus that was grown in a defined minimal medium (M. 
tuberculosis Sauton’s media) originally developed for mycobacteria (Sassetti et al., 2003). 
This medium was selected in this study because it is well defined, minimal, and 
protein/peptide free so as to facilitate proteomic analysis in the extension of this study. The 
acidification of the growth medium in stationary phase when asparagine and ammonium 
chloride were used as a nitrogen source by the S. albus: a drop in pH from the initial pH of 
7.4 to pH about 5.8. This drop in pH was also observed when M. tuberculosis and M. bovis 
BCG are cultured in Sauton’s medium containing ammonium chloride as a nitrogen 
source. Although was not confirmed in this study, the most likely reason for these 
observations is the excretion and accumulation of organic acids during stationary and late 
phases of growth. 
 
The profiles of enzyme activities in the four culture media tested (Sauton’s 
medium with the nitrogen source being either ammonium chloride, asparagine, nitrate, or 
glycine) were similar but with notable differences (Tables 5 and 6). Enzymes activities that 
were detected only in media with glycine as a nitrogen source include β-galactosidase, β-
glucosidase, and α-chymotrypsin. On the other hand, enzymes activities that were absent 
in this medium include β-glucuronidase and cysteine arylamidase. Another important 
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observation was that the profiles of enzymatic activities in the cytoplasmic fractions of the 
bacterium in the four culture media were different from those found in the secretory 
fractions, indicating that the latter are indeed secretory enzymes and not simply found in 
this fraction as a result of experimental error or cross contamination of the fractions during 
sample processing. These differences were confirmed by examining the protein banding 
pattern on SDS-PAGE (Figures 8 and 9). A previous study showed the activity of ten 
secreted enzymes by M. tuberculosis (Roman and Sicilia, 1984), eight enzymes activities 
out of those were also found in S. albus in this study. These enzyme activities were: 
alkaline phosphatase, esterase/lipases (C8), lipase (C14), leucine arylamidase, valine 
arylamidase, acid phosphatase, naphthol-AS-BI-phosphohydrolase, and β-glucosidase 
(Table 9).  
Consistent with these findings, Raynaud et al. (1998) examined the 
extracellular enzyme activities in the culture supernatant of M. tuberculosis. Eight 
enzyme activities were detected only in the culture fluids and/or on the cell surface of this 
pathogen that are involved with the pathogenicity of this species. Some the enzyme 
activities detected in the present study with S. albus include alanine dehydrogenase, 
catalase, peroxidase, and alcohol dehydrogenase. Acid phosphates and alkaline 
phosphatase activities previously detected in M. tuberculosis and other species of 
non-pathogenic mycobacteria such as M. smegmatis were also detected in this study in S. 
albus. Importantly, this study showed that these enzyme activities were detected in both 
the cytoplasmic and the secretory fraction (spent culture medium). 
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Table 9. Comparison of 19 enzymes activities between M. tuberculosis (M) and S. 
albus (S), using the API ZYM test. Eight enzyme activities were found in both 
bacteria.  (+) active (-) inactive. 
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The levels of the following  enzymes were further determined quantitatively: acid 
phosphatase, alkaline phosphatase, alanine dehydrogenase, alcohol dehydrogenase, 
and catalase/peroxidase (Table 10). Acid phosphatase was found in highest levels in the 
secretory fraction (CFP) of media containing glycine as a nitrogen source but was 
highest in the cytoplasmic fractions of cells grown with nitrate as a nitrogen source. This 
was interesting because this media did not show significant drop in pH as happened 
with media containing ammonium chloride and asparagine. This may indicate that this 
enzyme is not secreted in response to acid pH but is rather dependent on the nitrogen 
source directly. The highest activity of alkaline phosphatase was detected in the 
media with asparagine as a nitrogen source, also implicating its regulation in response 
to the nitrogen source directly  and not the pH of the medium.  
Nitrogen metabolism in streptomyces has been well defined. Nitrogen regulated 
genes (GlnR regulon) are under the control of the central repressor GlnR (Voelker and 
Altaba, 2001). This regulator controls the expression of three key enzyme systems 
involved in nitrogen assimilation: glutamine synthetase (GS), glutamate dehydrogenase 
(GDH), and glutamate synthase (GOGAT). These three enzymes assimilate inorganic 
nitrogen (ammonium ion or nitrate) into organic form through incorporation into glutamate 
and glutamine (Figure 25). Under high inorganic nitrogen conditions, as was used in this 
study, there will be accumulation of several organic acids such as 2-oxoglutarate and 
glutamate (Figure 25). It is therefore conceivable that the acidification of the media 
containing these nitrogen sources is due to excretion of excess 2-oxoglutarate and 
glutamate. In one study with S. lividans, excretion of 2-oxoglutarate as well as pyruvate 
was observed when the bacterium is cultured in media containing glucose as a carbon  
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Table 10. Summary of enzyme activity results that found mostly in the medium with 
glycine and sodium nitrate.  
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Figure 25. Control of nitrogen assimilation in streptomyces. Adapted from Voelker and 
Altaba (2001). 
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source and nitrate as a nitrogen source (Madden et al., 1996). In a similar study but with S. 
peucetius, the same organic acids were found to be excreted in culture media (Dekleva and 
Strohl, 1987). In this study, secretion of the acid phosphatase activity did not correlate with 
acidification of the media. Non-specific acid phosphatases (such as SapM) are typically 
regulated by inorganic phosphate levels rather than acid pH (Tiffert et al., 2008)  
Alanine dehydrogenase, alcohol dehydrogenase, and catalase/peroxidase showed 
highest levels in the CFP fraction of the media supplemented with nitrate as the nitrogen 
whereas it was highest in the cytoplasmic fraction of cells harvested from media with 
glycine as the nitrogen source. These enzymes were investigated in more details 
because of their potential involvement in the virulence of this pathogen. Another type of 
enzyme activity often implicated in the virulence of intracellular pathogens is 
metalloproteinases. This activity was assessed in both the secretory fraction and 
the cytoplasmic fraction of S. albus grown in all four media. Gelatinase zymography 
showed that the cytoplasmic  fractions of cells grown in Sauton’s media  with ammonium 
chloride  and  nitrate as nitrogen sources contained the highest activities. The zymograms 
showed two distinct major bands corresponding to approximately 120 kDa and 70 kDa 
and two minor bands at 48 kDa and 20 kDa (Figure 15). It is not known whether  these  
bands correspond to four distinct proteins or to proteolytic fragments of a fewer number of 
proteins. In the secretory fraction, one minor band was visible only in the medium with 
nitrate as a nitrogen source, corresponding to approximately 50 kDa in size.    
 The functional relatedness of S. albus and M. tuberculosis must be extended 
beyond similarity of enzymatic profiles. An important functional category is the 
immunological profile. While enzymatic profiles provide information on the 
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similarities in metabolism and protein secretion (with potential functions in 
pathogenesis), immunological profiles provide information on the capacity to provide a 
similar immunological response, a feature important in selecting a heterologous 
vaccine candidate. In this study, seven monoclonal antibodies specific for seven 
distinct antigens were used to screen for cross reactivity with the secretory  fractions 
of S. albus. Of the seven antibodies, only  one (F181-ID3-2) gave a positive hit. This is a 
monoclonal antibody directed at a specific internal amino acid sequence in the secreted 
acid phosphatase of mycobacteria (SapM). This protein has a size of about 28 kDa and is 
implicated in the pathogenesis of M. tuberculosis (Saleh and Belisle, 2000; Vergne et al., 
2005). All other antibodies were negative in their reactivity. One must keep in mind that 
these are monoclonal antibodies and are specific against small and well-defined 
epitopes and thus require a very high degree of homology between two different 
proteins from two different bacteria to give a positive reaction. Antibodies against 
Mycobacteria antigens also reacted with antigens from streptomyces, suggesting that not 
only  do they  share enzyme activities but also share protein sequences and has 
implications on relatedness of immunological responses induced by these related 
pathogens. 
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5. Conclusions 
 
      A significant aspect of the present work is the finding the quantities or 
qualitative evaluation of enzyme activity, of the 14 comparative enzymes ( acid 
phosphatase, alkaline phosphatase, peroxidase, protease, alanine dehydrogenase, alcohol 
dehydrogenase, catalase, superoxide dismutase, esterase, lipases (C8), lipase (C14), 
leucine arylamidase, valine arylamidase, naphthol-AS-BI-phosphohydrolase, and β–
glucosidase) are found in both S. albus and M. tuberculosis. This finding suggests that 
streptomyces and mycobacteria share similar growth and metabolic properties. On the 
other hand, the fact that some antibodies against mycobacteria antigens also react with 
antigens from streptomyces also suggests that not only  do they  share enzyme activities but 
also share protein sequences and has implications on relatedness of immunological 
responses induced by these related pathogens. 
      This enzymatic study confirms that both species are not only phylogenetically but 
also physiologically related. It also shows that these enzymatic profiles are dependent on 
the growth media used to culture the bacteria. This could be important in selecting the 
appropriate streptomyces species and in formulating the growth media for a vaccine 
candidate for TB.  
    The next objective will be to further investigate the immunological cross reactivity 
of these two actinobacteria and study the immune response to S. albus as a new live 
vaccine vehicle strategy against TB. An animal-based study whereby a genetically 
engineered S. albus or a related specie expressing specific antigens of M. tuberculosis is 
used for immunization and the animals are then challenged with an infectious dose of M. 
tuberculosis would be an appropriate line of investigation to follow. 
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